Trinity Biotech plc - American Depositary Shares (TRIB)
0.6780
-0.0720 (-9.60%)
NASDAQ · Last Trade: Jun 27th, 2:55 AM EDT
Via Benzinga · June 26, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · June 25, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · June 25, 2025
Via Benzinga · June 25, 2025
Via Benzinga · June 24, 2025

Via Benzinga · January 30, 2025

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.
Via Stocktwits · January 29, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · January 28, 2025

Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Via Chartmill · January 28, 2025

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · January 28, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · January 28, 2025

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · January 28, 2025

Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its continuous glucose monitoring system.
Via Benzinga · January 28, 2025

Via Benzinga · January 22, 2025

Via Benzinga · November 1, 2024

Via Benzinga · October 31, 2024

Via Benzinga · October 29, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 9, 2024

Via Benzinga · October 8, 2024

Trinity Biotech stock surges on high volume after announcing increased orders for TrinScreen HIV, boosting 2024 revenue projections to $10 million. Second-quarter earnings show a 14% YoY revenue increase driven by strong HIV test sales.
Via Benzinga · August 27, 2024